DE69918339D1 - Pharmazeutische zusammensetzungen die selegilin und ginkgo biloba extrakt enthalten zur behandlung von demenz - Google Patents

Pharmazeutische zusammensetzungen die selegilin und ginkgo biloba extrakt enthalten zur behandlung von demenz

Info

Publication number
DE69918339D1
DE69918339D1 DE69918339T DE69918339T DE69918339D1 DE 69918339 D1 DE69918339 D1 DE 69918339D1 DE 69918339 T DE69918339 T DE 69918339T DE 69918339 T DE69918339 T DE 69918339T DE 69918339 D1 DE69918339 D1 DE 69918339D1
Authority
DE
Germany
Prior art keywords
dementia
treatment
pharmaceutical compositions
compositions containing
ginkgo biloba
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69918339T
Other languages
English (en)
Other versions
DE69918339T2 (de
Inventor
Hyung Soo Ann
Jeong Mi Lee
Hyung Chun Kim
Sung An Kang
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Yuyu Inc
Original Assignee
Yuyu Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yuyu Inc filed Critical Yuyu Inc
Application granted granted Critical
Publication of DE69918339D1 publication Critical patent/DE69918339D1/de
Publication of DE69918339T2 publication Critical patent/DE69918339T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/16—Ginkgophyta, e.g. Ginkgoaceae (Ginkgo family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Biotechnology (AREA)
  • Hospice & Palliative Care (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Medical Informatics (AREA)
  • Psychiatry (AREA)
  • Botany (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Psychology (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DE69918339T 1999-04-21 1999-04-21 Pharmazeutische zusammensetzungen die selegilin und ginkgo biloba extrakt enthalten zur behandlung von demenz Expired - Fee Related DE69918339T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/KR1999/000189 WO2000064462A1 (en) 1999-04-21 1999-04-21 Pharmaceutical compositions containing selegiline and ginkgo biloba extract useful for dementia

Publications (2)

Publication Number Publication Date
DE69918339D1 true DE69918339D1 (de) 2004-07-29
DE69918339T2 DE69918339T2 (de) 2005-08-25

Family

ID=19570792

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69918339T Expired - Fee Related DE69918339T2 (de) 1999-04-21 1999-04-21 Pharmazeutische zusammensetzungen die selegilin und ginkgo biloba extrakt enthalten zur behandlung von demenz

Country Status (4)

Country Link
EP (1) EP1171146B1 (de)
CN (1) CN1251695C (de)
DE (1) DE69918339T2 (de)
WO (1) WO2000064462A1 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006004386A1 (es) * 2004-07-02 2006-01-12 Rojas Castaneda Patricia Uso de un extracto del ginkgo biloba para preparar una medicina para tratar la enfermedad de parkinson
KR100723609B1 (ko) * 2006-04-28 2007-06-04 주식회사 유유 신규한 조성의 알츠하이머형 치매 및 파킨슨씨병 예방 또는 치료용 은행잎 추출물, 그리고 은행잎으로부터의 추출 및 정제 방법

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9426079D0 (en) * 1994-12-23 1995-02-22 Orion Yhtymae Oy A gelatine capsule
ES2199283T5 (es) * 1995-03-02 2008-05-16 R.P. Scherer Technologies, Inc. Composiciones farmaceuticas que comprenden inhibidores de la monoamina oxidasa b.
JP4600610B2 (ja) * 1996-05-15 2010-12-15 株式会社フジモト・コーポレーション アセチルコリン系神経伝達改善剤

Also Published As

Publication number Publication date
EP1171146A1 (de) 2002-01-16
DE69918339T2 (de) 2005-08-25
CN1352564A (zh) 2002-06-05
WO2000064462A1 (en) 2000-11-02
EP1171146B1 (de) 2004-06-23
CN1251695C (zh) 2006-04-19

Similar Documents

Publication Publication Date Title
DE60118571D1 (de) Pharmazeutische zusammensetzungen zur behandlung von krebs welche thalidomid und topoisomerase inhibitoren enthalten
ATE265857T1 (de) Pharmazeutische oder diätetische zusammensetzung zur prävention oder behandlung von hyperoxalurie
DE60023128D1 (de) Pyrazolecarboxamide zur behandlung von fettleibigkeit und anderen erkrankungen
DE69929996D1 (de) Pharmazeutisches mittel zur behandlung von diabetes
ATE260652T1 (de) Arzneimittel und verfahren zur behandlung von aufmerksamkeitsstörungen und aufmerksamkeits- /hyperaktivitätsstörungen mit methylphenidat
ATE207755T1 (de) Pharmazeutische zusammensetzungen enthaltend lactobacillus brevis und lactobacillus salivarius zur behandlung von vaginainfektionen
DE69942680D1 (de) Verfahren und Zusammensetzungen zur Prävention und Behandlung von Anämie
IL147217A0 (en) New spirooxindole derivatives and pharmaceutical compositions containing the same for treatment of pain
HUP0204399A3 (en) Pteridine compounds for the treatment of psoriasis, process for their preparation, pharmaceutical compositions containing them and their use
ATE417602T1 (de) Mittel zur behandlung von erkrankungen der speiseröhre
DE69806801D1 (de) Galenische präparation zur prävention und behandlung von hepatokarzinomen
DE69718662D1 (de) Magnesium(-)hydroxycitrat, verfahren zur herstellung, anwendung und pharmazeutische zusammensetzungen, die sie enthalten
DE19580261D2 (de) Pharmazeutische Zubereitungen und Arzneistoffe zur Prävention und Behandlung endothelialer Dysfunktion
DE69532066D1 (de) Arzneimittel zur Behandlung von Restenosis und Gefässsklerose
DE59812049D1 (de) Pharmazeutische zusammensetzung zur behandlung von schlaganfall und schädel-hirn-trauma
DE60002226D1 (de) Zusammensetzung zur vorbeugung und/oder behandlung von kreislaufstörungen, enthaltend l-carnitin derivate und ginkgo biloba extrakte
ATE431142T1 (de) Arzneimittel zur behandlung und vermeidung neurogener schmerzen
NO20010627D0 (no) Anvendelse av Gingko Biloba ekstrakter for fremstilling av et medikament for behandling av amyotrofisk lateral sclerose
DE69838785D1 (de) Pharmazeutische mittel zur behandlung von zerebralen amyloidosis
DE69429101D1 (de) Verbindungen und zusammensetzungen zur behandlung von allergien und entzündungen
HUP0303797A3 (en) Method for preparing an extract of ginkgo biloba leaves highly enriched in active ingredients and pharmaceutical compositions containing it
DE69925578D1 (de) Pharmazeutische zusammenstellung zur vorbeugung und behandlung von mit zellkrankheiten des augenhintergrundes zusammenhängenden krankheiten
DE69420229D1 (de) Pharmazeutische Zusammensetzung zur Behandlung von AIDS
ATE247466T1 (de) Pharmazeutische zubereitungen enthaltend ibuprofen und domperidon zur behandlung von migräne
DE50010681D1 (de) Pharmazeutische zubereitung enthaltend zytostatika und elektronenakzeptoren zur behandlung von krebs

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee